This story was first published in digitalhealth.net
Advanced pancreatic cancer clinical trial
A clinical trial at University Hospital in Coventry is offering a new combination of treatments which could ultimately allow patients with advanced pancreatic cancer to live for longer.
The new HALO 301 trial will treat patients with two existing chemotherapies, nab-paclitaxel and gemcitabine, in combination with a new treatment called PEGPH20, an enzyme which breaks down hyaluronan. This should slow tumour growth, ultimately allowing patients to live for longer.
University Hospitals Coventry and Warwickshire reports that there are 820 patients diagnosed with pancreatic cancer each year in the West Midlands area.
Dr Scott-Brown, consultant clinical oncologist at the trust, said: “I’m delighted to be leading this innovative new trial in a disease area which has historically been neglected in terms of research and investment and joining Pancreatic Cancer UK in spreading the word about it to patients in the West Midlands. We hope it leads to not only a much-needed new treatment option for eligible patients with advanced disease, but also ultimately helps to improve survival rates and quality of life for many patients across the UK in the future.”
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
